The Bank of New York Mellon Corporation (BK) Earnings Expected to Grow: Should You Buy? — Positive

BK   Zacks Investment Research — October 09, 2025

The Bank of New York Mellon (BK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news The Bank of New York Mellon Corporation (BK) Earnings Expected to Grow: Should You Buy?

Intuitive Surgical, Inc. (ISRG) to Report Q3 Results: Wall Street Expects Earnings Growth — Positive

ISRG   Zacks Investment Research — October 09, 2025

Intuitive Surgical (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Intuitive Surgical, Inc. (ISRG) to Report Q3 Results: Wall Street Expects Earnings Growth

Citizens & Northern (CZNC) Earnings Expected to Grow: Should You Buy? — Neutral

CZNC   Zacks Investment Research — October 09, 2025

Citizens & Northern (CZNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Citizens & Northern (CZNC) Earnings Expected to Grow: Should You Buy?

Commercial Metals (CMC) Reports Next Week: Wall Street Expects Earnings Growth — Positive

CMC   Zacks Investment Research — October 09, 2025

Commercial Metals (CMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Commercial Metals (CMC) Reports Next Week: Wall Street Expects Earnings Growth

The Charles Schwab Corporation (SCHW) Earnings Expected to Grow: Should You Buy? — Positive

SCHW   Zacks Investment Research — October 09, 2025

Charles Schwab (SCHW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news The Charles Schwab Corporation (SCHW) Earnings Expected to Grow: Should You Buy?

KeyCorp (KEY) Earnings Expected to Grow: Should You Buy? — Positive

KEY   Zacks Investment Research — October 09, 2025

KeyCorp (KEY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news KeyCorp (KEY) Earnings Expected to Grow: Should You Buy?

Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral

MMC   Zacks Investment Research — October 09, 2025

Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Marsh & McLennan (MMC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Earnings Preview: CSX (CSX) Q3 Earnings Expected to Decline — Negative

CSX   Zacks Investment Research — October 09, 2025

CSX (CSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: CSX (CSX) Q3 Earnings Expected to Decline

Bank OZK (OZK) Reports Next Week: Wall Street Expects Earnings Growth — Positive

OZK   Zacks Investment Research — October 09, 2025

Bank OZK (OZK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Bank OZK (OZK) Reports Next Week: Wall Street Expects Earnings Growth

Travelers (TRV) Reports Next Week: Wall Street Expects Earnings Growth — Positive

TRV   Zacks Investment Research — October 09, 2025

Travelers (TRV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Travelers (TRV) Reports Next Week: Wall Street Expects Earnings Growth

M&T Bank Corporation (MTB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Positive

MTB   Zacks Investment Research — October 09, 2025

M&T Bank (MTB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news M&T Bank Corporation (MTB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Webster Financial (WBS) Earnings Expected to Grow: Should You Buy? — Positive

WBS   Zacks Investment Research — October 09, 2025

Webster Financial (WBS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Webster Financial (WBS) Earnings Expected to Grow: Should You Buy?

Bay Commercial Bank (BCML) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Bay Commercial Bank (BCML) to Report a Decline in Earnings: What to Look Out for

U.S. Bancorp (USB) Reports Next Week: Wall Street Expects Earnings Growth — Positive

USB   Zacks Investment Research — October 09, 2025

U.S. Bancorp (USB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news U.S. Bancorp (USB) Reports Next Week: Wall Street Expects Earnings Growth

Cass Information Systems (CASS) to Report Q3 Results: Wall Street Expects Earnings Growth — Positive

CASS   Zacks Investment Research — October 09, 2025

Cass (CASS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Cass Information Systems (CASS) to Report Q3 Results: Wall Street Expects Earnings Growth

Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models Preclinical data demonstrates proof-of-concept for EDIT-401 with ≥90% mean LDL-C reduction in non-human primates and mouse models

image for news Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress

Reflection AI, a startup backed by Nvidia, said on Thursday it has raised $2 billion in a new funding round that values the company at $8 billion, as investor interest in artificial intelligence remains unabated.

image for news Nvidia-backed Reflection AI raises $2 billion in funding, boosts valuation to $8 billion

C3is Inc. Announces Closing of $2 Million Registered Direct Offering — Neutral

CISS   GlobeNewsWire — October 09, 2025

ATHENS, Greece, Oct. 09, 2025 (GLOBE NEWSWIRE) -- C3is Inc. (NASDAQ: CISS) (the “Company”), a ship-owning company providing dry bulk and tanker seaborne transportation services, today announced the closing of its previously announced registered direct offering with institutional investors for the purchase and sale of 800,000 shares of its Common Stock at a public offering price of $2.50, for an aggregate offering price of $2.0 million.

image for news C3is Inc. Announces Closing of $2 Million Registered Direct Offering

AUBURN HILLS, Mich., Oct. 9, 2025 /PRNewswire/ -- Chrysler Pacifica spices up Halloween spirit with second year as the Official Minivan of Trunk or Treat Pacifica offers "hauntingly" helpful trunk-or-treat-ready features, including Stow 'n Go seating, Uconnect Theater, Stow 'n Vac and more Pacifica owners can share their own trunk-or treat creations on Chrysler brand social media channels For more information on Chrysler Pacifica, visit Chrysler.

image for news Spooktacular Sequel: Chrysler Pacifica Returns as Official Minivan of Trunk or Treat

MILWAUKEE , Oct. 9, 2025 /PRNewswire/ -- The Ademi Firm is investigating Akero (NASDAQ: AKRO) for possible breaches of fiduciary duty and other violations of law in its transaction with Novo Nordisk. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

image for news Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders